DUBLIN--(BUSINESS WIRE)--The "Global In Vitro Diagnostics (IVD) Market: Drivers, Opportunities, Trends and Forecasts: 2014 - 2020" report has been added to Research and Markets' offering.
The global in-vitro diagnostics market is estimated to witness a CAGR of 5.31% during the forecast period 2017-2023. The market is analyzed based on five segments - technology, application, test types, end-users, and regions.
Factors, such as increased sales of POC cardiac markers and increased adoption of DNA probe-based diagnostics are growth opportunities for the market players. The market is witnessing an emerging trend of companion diagnostics, cardiac biomarkers, POC markers, and other novel technologies that are helping in diagnosing the diseases at an early stage with precision. There has been a transition from diagnosis in core laboratories to diagnosis in front of the patient.
The markets in India, Brazil, and China are expected to grow at a rapid pace during the forecast period as the prevalence of infectious diseases and lifestyle diseases in these countries is high. These countries are set to be the target regions for the market players due to the large untapped potential.
The leader in IVD market is F. Hoffmann-La Roche, who is currently occupying 20% of the IVD market. Abbott, Siemens, Danaher, and ThermoFisher are the other major players in the market. These top players occupy around 56% of the market.
Key Topics Covered:
1 Industry Outlook
2 Report Outline
3 Market Snapshot
4 Market Outlook
5 Market Characteristics
6 By Technology: Market Size and Analysis
7 By Application: Market Size and Analysis
8 Test Types: Market Size and Analysis
9 End User: Market Size and Analysis
10 Regions: Market Size and Analysis
11 Competitive Landscape
12 Vendor Profiles
13 Companies to Watch For
- Abbott Laboratories
- Becton Dickinson and Company
- BioMerieux S.A.
- Bio-Rad Laboratories, Inc.
- Danaher Corporation.
- F.Hoffmann-La Roche Ltd
- Ortho Clinical Diagnostics (Carlyle Group)
- Qiagen NV
- Siemens Healthineers Inc.
- Sysmex Corp.
- Thermo Fisher Scientific Inc.
For more information about this report visit https://www.researchandmarkets.com/research/48phfr/global_in_vitro